New Drugs U.S. FDA Approves Fulphila (pegfilgrastim-jmdb), the First Biosimilar to Neulasta 7 years ago
Pharma Industry News Daily Brief: ASCO latest, Europe cautions on immunotherapy, rejects Duchenne treatment 7 years ago